Does REMDESIVIR Cause Hypertransaminasaemia? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Hypertransaminasaemia have been filed in association with REMDESIVIR (Veklury). This represents 0.6% of all adverse event reports for REMDESIVIR.
65
Reports of Hypertransaminasaemia with REMDESIVIR
0.6%
of all REMDESIVIR reports
6
Deaths
20
Hospitalizations
How Dangerous Is Hypertransaminasaemia From REMDESIVIR?
Of the 65 reports, 6 (9.2%) resulted in death, 20 (30.8%) required hospitalization, and 2 (3.1%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
Yes, Hypertransaminasaemia is listed as a known adverse reaction in the official FDA drug label for REMDESIVIR.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which REMDESIVIR Alternatives Have Lower Hypertransaminasaemia Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN